ArticleOncology and therapy2022

Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the Literature.

Sara Baglivo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.